EATG » Tuberculosis

Tuberculosis

France pledges €1.08 billion to Global Fund

PARIS - The Government of France announced today (June 26) it will contribute €1.08 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria for the three-year period beginning…

Italy makes strong commitment to Global Fund

ROME - The Government of Italy announced today (June 27) a pledge of €130 million to the Global Fund to Fight AIDS, Tuberculosis and Malaria for the three-year period beginning…

Faster detection of pathogens in the lungs

What used to take several weeks is now possible in two days: Thanks to new molecular-based methods, mycobacterial pathogens that cause pulmonary infections or tuberculosis can now be detected much…

Aeras provides update on Phase 2 trial of H4:IC31

H4:IC31 is a novel TB vaccine candidate being developed jointly by Aeras and Sanofi Pasteur. Phase 2 trial (C-040-404/TUB09) of H4:IC31 is designed to evaluate BCG and H4:IC31 for the…

Call to Action to accelerate access to DR-TB drugs: 2016 update

The update informs about the general progress in the introduction of bedaquiline and delamanid in TB programs worldwide and reports on the requests made in the Call to Action issued…

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 290 of the “Global Fund Observer.” The newsletter features articles…

Eastern European and Central Asian network of people with experience of TB launched

20 June 2016 – Bratislava, Slovakia – The TB Europe Coalition, in collaboration with and with support from the Stop TB Partnership launched TBpeople, the Eastern European and Central Asian…

Global Fund and Stop TB Partnership sign Memorandum of Understanding with Global Drug Facility

17 June 2016 - Geneva, Switzerland - The Stop TB Partnership today signed a Memorandum of Understanding (MOU) with the Global Fund to Fight AIDS, Tuberculosis and Malaria to optimize…

WHO recommendations on shorter MDR-TB treatment

The recent release by WHO of new recommendations aimed at speeding up tuberculosis drug susceptibility testing using a rapid molecular MTBDRsl test and use of shorter multidrug-resistant tuberculosis (MDR-TB) treatment…

Frequently asked questions on shorter MDR-TB regimen

The World Health Organization (WHO)'s Global TB Programme has released Frequently asked questions about the implementation of the new WHO recommendation on the use of the shorter MDR-TB regimen under…

1 28 29 30